These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 19720139)
1. Isolation of cancer-specific chimeric transcripts induced by hypomethylation of the LINE-1 antisense promoter. Cruickshanks HA; Tufarelli C Genomics; 2009 Dec; 94(6):397-406. PubMed ID: 19720139 [TBL] [Abstract][Full Text] [Related]
2. Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription. Weber B; Kimhi S; Howard G; Eden A; Lyko F Oncogene; 2010 Oct; 29(43):5775-84. PubMed ID: 20562909 [TBL] [Abstract][Full Text] [Related]
3. Selective changes of retroelement expression in human prostate cancer. Goering W; Ribarska T; Schulz WA Carcinogenesis; 2011 Oct; 32(10):1484-92. PubMed ID: 21828060 [TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917 [TBL] [Abstract][Full Text] [Related]
5. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822 [TBL] [Abstract][Full Text] [Related]
6. Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites. Sadikovic B; Haines TR; Butcher DT; Rodenhiser DI Breast Cancer Res; 2004; 6(4):R329-37. PubMed ID: 15217500 [TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139 [TBL] [Abstract][Full Text] [Related]
8. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
9. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Neidhart M; Rethage J; Kuchen S; Künzler P; Crowl RM; Billingham ME; Gay RE; Gay S Arthritis Rheum; 2000 Dec; 43(12):2634-47. PubMed ID: 11145021 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of gelsolin expression in human breast cancer cells. Mielnicki LM; Ying AM; Head KL; Asch HL; Asch BB Exp Cell Res; 1999 May; 249(1):161-76. PubMed ID: 10328963 [TBL] [Abstract][Full Text] [Related]
11. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [TBL] [Abstract][Full Text] [Related]
12. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122 [TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230 [TBL] [Abstract][Full Text] [Related]
14. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency. Periyasamy S; Ammanamanchi S; Tillekeratne MP; Brattain MG Oncogene; 2000 Sep; 19(40):4660-7. PubMed ID: 11030155 [TBL] [Abstract][Full Text] [Related]
16. Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines. Schaefer M; Hagemann S; Hanna K; Lyko F Cancer Res; 2009 Oct; 69(20):8127-32. PubMed ID: 19808971 [TBL] [Abstract][Full Text] [Related]
17. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation. Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression. Ai L; Kim WJ; Kim TY; Fields CR; Massoll NA; Robertson KD; Brown KD Cancer Res; 2006 Aug; 66(16):7899-909. PubMed ID: 16912163 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells. Cho CY; Wang JH; Chang HC; Chang CK; Hung WC J Cell Physiol; 2007 Oct; 213(1):65-9. PubMed ID: 17443689 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells. Ikeda JI; Morii E; Kimura H; Tomita Y; Takakuwa T; Hasegawa JI; Kim YK; Miyoshi Y; Noguchi S; Nishida T; Aozasa K J Pathol; 2006 Sep; 210(1):75-84. PubMed ID: 16823897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]